Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide A.Bruce E. Maryanoff, Aimin Liu, Xiayang Qiu et al.|Proceedings of the National Academy of Sciences|1993Cited by 109
Macrocyclic Peptide Inhibitors of Serine Proteases. Convergent Total Synthesis of Cyclotheonamides A and B via a Late-Stage Primary Amine Intermediate. Study of Thrombin Inhibition under Diverse ConditionsBruce E. Maryanoff, Peter Brungs, Michael N. Greco et al.|Journal of the American Chemical Society|1995Cited by 87
Discovery of a Novel Series of Pyridone-Based EP3 Antagonists for the Treatment of Type 2 DiabetesXuqing Zhang, Mark J. Macielag, Bin Zhu et al.|ACS Medicinal Chemistry Letters|2021Cited by 6
Optimization of physicochemical properties of pyridone-based EP3 receptor antagonistsXuqing Zhang, Mark J. Macielag, Matthew M. Rankin et al.|Bioorganic & Medicinal Chemistry Letters|2021Cited by 5
Macrocyclic Peptide Inhibitors of Serine Proteases. Convergent Total Synthesis of Cyclotheonamides A and B via a Late-Stage Primary Amine Intermediate. Study of Thrombin Inhibition under Diverse Conditions. [Erratum to document cited in CA122:161323]Bruce E. Maryanoff, Peter Brungs, Michael N. Greco et al.|Journal of the American Chemical Society|1995Cited by 3